Market Cap | $8.33M |
Volume (M) | 52,893.00 |
52-Wk High | $3.14 |
52-Wk Low | $0.395 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Cadrenal Therapeutics Inc market cap is $8.33M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cadrenal Therapeutics Inc 52 week high is $3.14 as of March 28, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cadrenal Therapeutics Inc 52 week low is $0.395 as of March 28, 2024.
Cadrenal Therapeutics Inc stock price today is $0.61.
Cadrenal Therapeutics Inc stock price yesterday was $0.64.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cadrenal Therapeutics Inc’s P/E ratio is -0.92.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Cadrenal Therapeutics Inc P/B ratio is 1.0835.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Cadrenal Therapeutics Inc's EBITDA is -0.16.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cadrenal Therapeutics Inc 50-day moving average is $0.8871.
Cadrenal Therapeutics Inc has 4 employees.
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here or